ArticleNeurobiology of disease2012

Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.

Haiqun Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.